Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor ...

Results from the company’s Phase II trial also saw PL8177 elicit a clinical response in 77% of ulcerative colitis patients.

Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...

Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...

Capital, Aurora Capital and Platinum Equity are among the PE firms investing in the pharma packaging and storage services ...

Verona Pharma (VRNA) has amended its existing strategic financing agreements by repaying the revenue interest purchase and sale agreement and ...

Bayswater Exploration and Production LLC, a Denver-based oil and natural-gas development company, has closed the sale of ...

Iconic "dollar" star Dollar Tree has already raised its standard price once, increasing the standard price of its products ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

The Boeing Company outpaces Airbus SE in deliveries amid engine supply issues, while both stocks show strong buy potential.

The Memphis Grizzlies have parted ways with their winningest coach, Taylor Jenkins, with the team struggling down the stretch ...

Deion Sanders could be sticking around Boulder for at least a few more years after the University of Colorado head football ...